Skip to main
ALLO
ALLO logo

ALLO Market Capitalization Overview

Market Cap: $306.23M as of Jun 12, 2025

$306.23M
Past Month+$50.34M (19.67%)
As of Jun 12, 2025, ALLO has a market capitalization of $306.23M. Over the past 30 days, its market cap has decreased by -24.34%, while in the last 12 months, it has decreased by -31.43%.

Market capitalization represents the total value of Allogene Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

ALLO Market Cap Formula = Stock Price * Shares Outstanding

The market cap of ALLO helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ALLO Market Cap History

DateMarket CapChange
Jun 2, 2025$277.79M-24.34%
May 1, 2025$367.18M+23.36%
Apr 1, 2025$297.66M-21.13%
Mar 3, 2025$377.41M+7.78%
Feb 3, 2025$350.16M-24.09%
Jan 2, 2025$461.28M-13.73%

ALLO End of Year Market Cap History

DateMarket CapChange
2025$306.23M-31.43%
2024$446.61M-17.32%
2023$540.17M-40.45%
2022$907.09M-57.34%
2021$2.13B-39.95%
2020$3.55B

FAQs About Allogene Therapeutics Inc (ALLO) Market Cap

As of Jun 12, 2025, the market capitalization of ALLO is $306.23M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Allogene Therapeutics Inc’s market capitalization has increased by 19.67%, changing from $255.89M to $306.23M as of Jun 12, 2025.

In the last 3 months, Allogene Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Allogene Therapeutics Inc’s market capitalization decreased from $540.17M in January to $446.61M in December, reflecting a -17.32% change.

In the past five years, ALLO has had a compound annual growth rate (CAGR) of -33.91% in market capitalization. This means its market cap has shrunk at an average rate of -33.91% per year.

Allogene Therapeutics Inc (ALLO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.